Medical Equipment

Lyme Disease Testing Market Forecast 2026–2035 Highlighting Market Data Patterns and Industry Insights

March 13, 2026March 16, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Lyme Disease Testing Market Over The Period 2026–2030?

The market size for lyme disease testing has shown significant growth over recent years. It is anticipated to increase from $10.68 billion in 2025 to $11.67 billion in 2026, registering a compound annual growth rate (CAGR) of 9.3%. This historical expansion can be linked to several factors, including the rising occurrence of lyme disease, inadequate public knowledge concerning early detection, a reliance on conventional serological tests, an uptick in hospital-based diagnostic services, and expanding research into tick-borne illnesses.

The Lyme disease testing market is projected to experience substantial expansion over the coming years. Its size is anticipated to reach $16.46 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.0%. This growth during the forecast period is fueled by factors such as the integration of AI-assisted diagnostics, the rise of home-testing kits, the development of multi-disease panels, increased government investment in tick-borne disease monitoring, and the adoption of cloud-based laboratory data management systems. Key developments expected during this period include the wider availability of point-of-care testing, the proliferation of home-based Lyme disease diagnostics, the emergence of multi-pathogen tick-borne panels, the increased use of rapid test kits, and the implementation of personalized diagnostic protocols.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25817&type=smp

Which Economic Or Industry Drivers Are Impacting The Lyme Disease Testing Market?

An increasing occurrence of tick-borne diseases is projected to drive the expansion of the lyme disease testing market in the future. These conditions encompass various diseases passed to humans via the bite of infected ticks, which are minute, blood-sucking parasites common in grassy, wooded, and rural environments. The growing need for treatments for these illnesses is intensified by the broader distribution of ticks due to climate change, resulting in increased exposure and rates of infection. As the main way Lyme disease is transmitted, tick-borne illnesses boost the demand for lyme disease testing, making early identification and diagnosis crucial for managing the increasing number of infection cases. For example, data from March 2025 by the U.S. Centers for Disease Control and Prevention (CDC), a federal public health agency in the U.S., showed that in 2023, more than 89,000 cases of Lyme disease were documented, indicating an ongoing significant impact of tick-borne illnesses when contrasted with prior years. Consequently, the increasing occurrence of tick-borne illnesses is a key factor propelling the expansion of the lyme disease testing market.

How Is The Lyme Disease Testing Market Divided Into Its Major Segments?

The lyme disease testing market covered in this report is segmented –

1) By Test Type: Serological Tests, Nucleic Acid Tests, Urine Antigen Tests, Other Test Types

2) By Testing Methodology: Enzyme-Linked Immunosorbent Assay (ELISA), Weste Blot, Polymerase Chain Reaction (PCR), Immunofluorescence Assay (IFA), Other Emerging Technologies

3) By Disease Stage: Early Lyme Disease, Disseminated Lyme Disease, Chronic Lyme Disease, Asymptomatic Lyme Disease Detection

4) By Sample Type: Blood, Urine, Cerebrospinal Fluid(CSF), Other Blood Samples

5) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Home Care Settings, Research Institutions, Public Health Organizations

Subsegments:

1) By Serological Tests: Enzyme-Linked Immunosorbent Assay, Western Blot, Immunofluorescence Assay (IFA), Line Immunoassay (LIA)

2) By Nucleic Acid Tests: Polymerase Chain Reaction (PCR), Loop-Mediated Isothermal Amplification (LAMP), Next-Generation Sequencing (NGS)

3) By Urine Antigen Tests: Lateral Flow Assay, Enzyme Immunoassay (EIA), Immunoblot Urine Tests

4) By Other Test Types: Culture-Based Tests, Tick-Borne Co-Infection Panels, Artificial Intelligence-Assisted Diagnostic Tools

How Are Trends Transforming The Lyme Disease Testing Market Landscape?

Companies prominently involved in the Lyme disease testing market are prioritizing technological enhancements in diagnostic tools to boost test accuracy, shorten turnaround times, and allow for early disease detection. Diagnostic tools include medical devices, kits, or technologies employed to identify Lyme disease by locating specific antibodies, antigens, or genetic material connected to the Borrelia burgdorferi bacteria. As an illustration, in August 2024, EpitogenX Ltd., a biotechnology company from the UK, declared the release of an innovative Lyme Disease Diagnostic Kit. This is an ELISA-based assay created using their unique EpitoGen platform. It contains ~120 different Borrelia epitopes, delivering high specificity and sensitivity, and is designed for research use (RUO). The kit facilitates early, strain-specific detection and can be modified for various laboratory applications. Being developed for both research and diagnostic laboratories, it is well-suited for improving detection precision and yielding greater insights into Lyme disease.

Who Are The Prominent Organizations Shaping The Lyme Disease Testing Market?

Major companies operating in the lyme disease testing market are Roche Holding AG, Thermo Fisher Scientific Inc., Labcorp Holdings Inc., Quest Diagnostics Incorporated, Eurofins Scientific, BIOMÉRIEUX, Quidel Corporation, Bio Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A, Meridian Bioscience, Trinity Biotech, T2 Biosystems, IGeneX, Viramed Biotech AG, Ceres Nanosciences, Galaxy Diagnostics, Lyme Diagnostics Ltd, Abbott Laboratories, Siemens Healthineers AG, Hologic Inc., Seegene Inc.

Read the full lyme disease testing market report here:

https://www.thebusinessresearchcompany.com/report/lyme-disease-testing-global-market-report

What Are The Top-Performing Regions Within The Lyme Disease Testing Market?

North America was the largest region in the lyme disease testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lyme disease testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Lyme Disease Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25817&type=smp

Browse Through More Reports Similar to the Global Lyme Disease Testing Market 2026, By The Business Research Company

Biologics Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

Covid 19 Saliva Screening Test Potential Market Report 2026

https://www.thebusinessresearchcompany.com/report/covid-19-saliva-screening-test-potential-global-market-report

Typhoid Antibody Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/typhoid-antibody-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795